Relationship between high-sensitivity cardiac troponin T, B-type natriuretic peptide, and physical function in

Kensuke Ueno1, Kentaro Kamiya1,2, Nobuaki Hamazaki3

  • 1Department of Rehabilitation Sciences, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Japan.

ESC Heart Failure
|September 7, 2021
PubMed

Insights

Higher levels of high-sensitivity cardiac troponin T (hs-cTnT) and B-type natriuretic peptide (BNP) are linked to reduced physical function in heart failure (HF) patients. hs-cTnT showed a stronger association, suggesting its utility in assessing physical function in HF.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Research

Background:

  • High-sensitivity cardiac troponin T (hs-cTnT) and B-type natriuretic peptide (BNP) are established prognostic markers in heart failure (HF).
  • The relationship between these biomarkers and objective measures of physical function in HF patients remains incompletely understood.

Purpose of the Study:

  • To investigate the association between hs-cTnT and BNP levels and physical function in patients diagnosed with heart failure.
  • To determine if hs-cTnT and BNP can predict limitations in physical performance in this population.

Main Methods:

  • Evaluated hs-cTnT, BNP, maximal quadriceps isometric strength (QIS), usual gait speed, and 6-min walk distance (6MWD) in 363 HF patients.
  • Patients were stratified into four groups based on median hs-cTnT and BNP levels.
  • Statistical analyses adjusted for demographic factors, laboratory results, and HF severity.

Main Results:

  • Elevated hs-cTnT and BNP levels were significantly associated with decreased QIS, usual gait speed, and 6MWD.
  • hs-cTnT demonstrated a more consistent inverse relationship with all measured physical function parameters.
  • Patients in the high hs-cTnT and high BNP group exhibited significantly poorer physical function compared to those in the low hs-cTnT and low BNP group.

Conclusions:

  • Both hs-cTnT and BNP are independently associated with reduced physical function in heart failure patients.
  • hs-cTnT appears to be a more robust predictor of physical function deficits than BNP.
  • Combined assessment of hs-cTnT and BNP may enhance the stratification of physical function capacity in individuals with HF.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
267
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
106
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
437
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
194
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
74